Medicis Announces Approval Of Additional Strengths Of Solodyn(R)
Main Category: Dermatology
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 31 Aug 2010 – 1:00 PDT
email to a friend printer friendly opinions
<!– rate article
Medicis (NYSE:MRX) announced that the U.S. Food and Drug Administration (FDA) has
approved additional strengths of SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets in [...]